In focus · trending topic

Acute Lymphoblastic Leukemia

2 stories · following the connections

ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F

By Nasdaq OMXApr 24, 2018, 8:30 PM UTC

ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018

By Nasdaq OMXApr 12, 2018, 5:30 AM UTC